Dr Meredith McKean Shares New Melanoma Studies, Treatment Developments

Source: AJMC, September2023

Meredith McKean, MD, MPH, the associate director of the Sarah Cannon Research Institute’s Melanoma and Skin Cancer Research Program at Tennessee Oncology, discussed new melanoma studies and treatment developments.

Meredith McKean, MD, MPH, of Tennessee Oncology discussed new melanoma studies and treatment developments she presented at The American Journal of Managed Care®’s Institute for Value-Based Medicine® hosted by Minnesota Oncology in Minneapolis, MN on September 12. McKean is the associate director of the Sarah Cannon Research Institute’s Melanoma and Skin Cancer Research Program at Tennessee Oncology. She specializes in skin cancer treatment and research, as well as phase 1 drug development.

Transcript
Can you briefly describe the new melanoma studies that you discussed at the Minnesota Oncology IVBM?
READ THE ORIGINAL FULL ARTICLE